DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

Baird Maintains Outperform on Global Medical REIT, Raises Price Target to $17

Baird maintains Global Medical REIT (NYSE:GMRE) with a Outperform and raises the price target from $14 to $17.

Benzinga · 03/06/2020 13:54

Baird maintains Global Medical REIT (NYSE:GMRE) with a Outperform and raises the price target from $14 to $17.